AA
VIRX

AlphaCentric Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

AlphaCentric Advisors’s Portfolio VIRX Stock Details VIRX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$329K Sell
90,000
-2,402
-3% -$8.78K 0.1% 78
2021
Q3 		$741K Hold
92,402
– – 0.19% 49
2021
Q2 		$1.05M Hold
92,402
– – 0.28% 23
2021
Q1 		$855K Buy
+92,402
New +$855K 0.29% 28